A case report of mycobacterium avium complex peritonitis in an AIDS patient

Yihenew Negatu1, Eyasu Mekonen

  • 1Department of Medicine, Howard University Hospital, 2041 Georgia Avenue, NW, Washington, DC 20060, USA.

Insights

Mycobacterium avium complex (MAC) peritonitis is rare, especially in patients with advanced AIDS and low CD4 counts. Early consideration of MAC peritonitis in AIDS patients with vague abdominal symptoms is crucial for timely treatment and improved outcomes.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Gastroenterology

Background:

  • Mycobacterium avium complex (MAC) infections are opportunistic pathogens, posing a significant risk to individuals with advanced Human Immunodeficiency Virus (HIV) infection and severely compromised immune systems (low CD4 counts).
  • While disseminated MAC commonly affects organs like the spleen, lymph nodes, liver, and intestines, peritoneal involvement is exceptionally rare.
  • Peritonitis, inflammation of the peritoneum, can arise from various causes, but MAC-induced peritonitis is an uncommon presentation.

Purpose of the Study:

  • To report a rare case of Mycobacterium avium complex (MAC) peritonitis in a patient with acquired immunodeficiency syndrome (AIDS).
  • To highlight the importance of considering MAC peritonitis in the differential diagnosis of abdominal symptoms in immunocompromised patients.
  • To emphasize the clinical presentation and successful treatment of this rare condition.

Main Methods:

  • A case study of a 26-year-old female patient diagnosed with AIDS and presenting with symptoms suggestive of peritonitis.
  • Review of the patient's clinical presentation, including abdominal pain, distension, anorexia, diarrhea, and cough.
  • Documentation of the treatment regimen and patient's response.

Main Results:

  • The patient, diagnosed with AIDS and noncompliant with highly active antiretroviral therapy (HAART), presented with nonspecific abdominal symptoms.
  • Diagnosis of MAC peritonitis was considered, and the patient was treated with a combination of rifabutin, clarithromycin, and ethambutol.
  • Adjunctive therapy with atovaquone was administered for Pneumocystis jiroveci pneumonia prophylaxis, leading to significant clinical improvement.

Conclusions:

  • Mycobacterium avium complex (MAC) peritonitis is an infrequent but serious complication in patients with advanced AIDS and low CD4 counts.
  • Nonspecific abdominal symptoms in the context of AIDS and severe immunosuppression warrant consideration of MAC peritonitis.
  • Prompt diagnosis and appropriate multi-drug antimicrobial therapy, alongside antiretroviral therapy and prophylaxis, can lead to favorable outcomes in MAC peritonitis.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.8K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.5K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84